ARIA opportunity seed research grant · Healthtech
Coherence Neuro receives £500,000 ARIA grant for brain cancer research
The award supports an 18-month project investigating electrical approaches to tumour signalling.
Coherence Neuro received a £500,000 research grant from the UK’s Advanced Research + Invention Agency for work investigating electrical approaches to brain cancer. ARIA’s transparency report records an 18-month award to the company, then named Opto Biosystems, dated May 30, 2025. The agency announced the named research projects that November.
Led by Jake Stroud, the project will explore whether electrical stimulation can interrupt signals associated with tumour growth. The team plans to use neural interfaces to investigate these mechanisms and compare approaches to treatment.
Use of funds
Research into tumour-targeted electrical stimulation
Funding history
ARIA opportunity seed research grant · This round£500K
Seed$10MSPARCLE research grant project disclosed July 2025£720.3KInnovate UK Smart grant£346.4KDecember 2022 pre-seed announced March 2023£1.9MCancer Tech Accelerator grant disclosed August 2022£70KSources
- ARIA announces Scalable Neural Interfaces opportunity seed projectslinkedin.com · Nov 6, 2025
- ARIA funded project: A Silence Switch for Canceraria.org.uk
- Coherence confirms ARIA competitive research fundinglinkedin.com · Dec 5, 2025
- ARIA Q1 FY25/26 signed grants: Opto Biosystems GBP500000app-aria-cm-prod.azurewebsites.net